Adequate posology of antimicrobial therapy in the septic critically ill in continuous veno-venous hemofiltration: a single centre prospective observational study
Journal of Antimicrobial Chemotherapy · 2025
DOI: 10.1093/jac/dkaf089 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Alberto Corona und 5 weiteren Autor:innen. Beteiligte Einrichtung: Accident & Emergency and Anaesthesia and Intensive Care Medicine Department, Esine and Edolo Hospitals, ASST Valcamonica, 25040 Brescia, Italy. Hauptthemen laut MEDLINE: Sepsis, Anti-Bacterial Agents, Continuous Renal Replacement Therapy, Hemofiltration. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben.
Abstract (Originalsprache)
Background
Determining the optimal antibiotic (ATB) dosage in septic critically ill patients on continuous renal replacement therapy (CRRT) is still challenging. CRRT further disrupts antibiotic PK, already altered by sepsis-induced fluid shifts, volume of distribution (VD) changes and half-life modifications. Materials and methods Our multi-disciplinary team—comprising an intensivist, nephrologist and clinical pharmacologist—conducted a prospective observational cohort study to evaluate the extent of ATB removal by CRRT and to assess the pharmacokinetic/pharmacodynamic (PK/PD) parameters of the most commonly used antibiotics for treating severe infections.
Results
A total of 135 ATB therapeutic drug monitoring (TDM) assessments were conducted, measuring total drug concentrations (C) in both plasma (P) and ultrafiltrate in 85 septic patients undergoing CRRT. A high sieving coefficient (∼75%) was recorded for all antibiotics, with CRRT-related drug loss described by the following equations: (i) [CUF-ATB](trough level) = 0.77 × [CP-ATB](trough level) + 0.93 ng/mL; (ii) [CUF-ATB](peak) = 0.77 × [CP-ATB](peak) + 3.1 ng/mL. The VD exhibited wide variability, with values exceeding those reported in the literature. Lower ATB molecular weight and steric hindrance were associated with a higher elimination rate constant (Kemin⁻¹). ATB TDM consistently correlated with AUC and AUC/MIC, ensuring effective bactericidal activity.
Conclusions
Despite its limitations, our study suggests to carry out a loading dose for the main antibiotics and consider the daily drug loss, as identified by the linear regression equation, along with daily TDM to guide further dosing adjustments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Accident & Emergency and Anaesthesia and Intensive Care Medicine Department, Esine and Edolo Hospitals, ASST Valcamonica, 25040 Brescia, Italy.
- Intensive Care Unit, ASST Fatebenefratelli Sacco, Polo Universitario, Via GB Grassi 74, PO Luigi Sacco, Milano 20157, Italy.
- Intensive Care Unit, ASST Ovest Milanese, Via Giovanni Paolo II, Legnano 20025, Italy.
- Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco University Hospital, Via GB Grassi 74, Milan 20157, Italy.
- Department of Anestesiology, Pain Medicine and Perioperative Care, University of Washington, Seattle, WA, USA.
ORCID-Profile: Alberto Corona, Dario Cattaneo
Zitieren
APA
Corona, A., Veronese, A., Santini, S., Santorsola, C., Cattaneo, D., & Shuman, M. (2025). Adequate posology of antimicrobial therapy in the septic critically ill in continuous veno-venous hemofiltration: a single centre prospective observational study. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf089
Vancouver
Corona A, Veronese A, Santini S, Santorsola C, Cattaneo D, Shuman M. Adequate posology of antimicrobial therapy in the septic critically ill in continuous veno-venous hemofiltration: a single centre prospective observational study. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf089
BibTeX
@article{Corona2025,
author = {Corona, Alberto and Veronese, Alice and Santini, Silvia and Santorsola, Clemente and Cattaneo, Dario and Shuman, Miryam},
title = {Adequate posology of antimicrobial therapy in the septic critically ill in continuous veno-venous hemofiltration: a single centre prospective observational study},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
doi = {10.1093/jac/dkaf089}
}
EUVIMED